195 related articles for article (PubMed ID: 8497907)
21. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model.
Morita S; Shinoda K; Yoshida T; Shimoda M; Kanno Y; Mizuno R; Kono H; Asanuma H; Nakagawa K; Umezawa K; Oya M
BMC Pharmacol Toxicol; 2020 Aug; 21(1):60. PubMed ID: 32787951
[TBL] [Abstract][Full Text] [Related]
22. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.
Cvetkovic M; Mann GN; Romero DF; Liang XG; Ma Y; Jee WS; Epstein S
Transplantation; 1994 Apr; 57(8):1231-7. PubMed ID: 7513912
[TBL] [Abstract][Full Text] [Related]
23. Prednisone alters the histopathology of chronic cyclosporine nephropathy.
Stillman IE; English J; Burdmann EA; Andoh TF; Franschini N; Bennett WM; Rosen S
Exp Nephrol; 1997; 5(1):61-8. PubMed ID: 9052850
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Sun QL; Li M; Rui HL; Chen YP
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: a morphometric analysis.
Potier M; Wolf A; Cambar J
Nephrol Dial Transplant; 1998 Jun; 13(6):1406-11. PubMed ID: 9641169
[TBL] [Abstract][Full Text] [Related]
26. Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity.
Li C; Yang CW; Ahn HJ; Kim WY; Park CW; Park JH; Lee MJ; Yang JH; Kim YS; Bang BK
J Lab Clin Med; 2002 Jun; 139(6):364-71. PubMed ID: 12066135
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
[TBL] [Abstract][Full Text] [Related]
28. Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury.
Rosen S; Greenfeld Z; Brezis M
Transplantation; 1990 Feb; 49(2):445-52. PubMed ID: 2305470
[TBL] [Abstract][Full Text] [Related]
29. Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition.
Gardner MP; Houghton DC; Andoh TF; Lindsley J; Bennett WM
Transplantation; 1996 May; 61(10):1506-12. PubMed ID: 8633380
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine A exhibits gender-specific nephrotoxicity in rats: Effect on renal tissue inflammation.
El-Bassossy HM; Eid BG
Biochem Biophys Res Commun; 2018 Jan; 495(1):468-472. PubMed ID: 29127010
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
[TBL] [Abstract][Full Text] [Related]
32. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
Li C; Yang CW; Kim WY; Jung JY; Cha JH; Kim YS; Kim J; Bennett WM; Bang BK
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F389-98. PubMed ID: 12529276
[TBL] [Abstract][Full Text] [Related]
33. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice.
Park HS; Kim EN; Kim MY; Lim JH; Kim HW; Park CW; Yang CW; Jin DC; Choi BS
Transpl Immunol; 2016 Feb; 34():42-9. PubMed ID: 26603313
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
Kawashima H; Mochizuki M; Okumura A; Fujino Y; Tange T; Horiuchi D; Higashihara E; Kaku H; Inaba G
Jpn J Ophthalmol; 1989; 33(4):425-40. PubMed ID: 2625778
[TBL] [Abstract][Full Text] [Related]
35. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats.
Kon V; Hunley TE; Fogo A
Transplantation; 1995 Jul; 60(1):89-95. PubMed ID: 7624949
[TBL] [Abstract][Full Text] [Related]
36. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine analogues.
Jeffery JR
Clin Biochem; 1991 Feb; 24(1):15-21. PubMed ID: 2060128
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine A versus cyclosporine G: a comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice.
Masri MA; Naiem M; Pingle S; Daar AS
Transpl Int; 1988 Apr; 1(1):13-8. PubMed ID: 3254185
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism.
Anjaneyulu M; Tirkey N; Chopra K
Ren Fail; 2003 Sep; 25(5):691-707. PubMed ID: 14575278
[TBL] [Abstract][Full Text] [Related]
40. Amelioration of cyclosporine nephrotoxicity by irbesartan, A selective AT1 receptor antagonist.
Chander V; Singh D; Tirkey N; Chander H; Chopra K
Ren Fail; 2004 Sep; 26(5):467-77. PubMed ID: 15526904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
